Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature.
about
Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophyInfections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyQuantitative and qualitative differences in subcutaneous adipose tissue stores across lipodystrophy types shown by magnetic resonance imaging.Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey.Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C > T LMNA mutation.The clinical approach to the detection of lipodystrophy - an AACE consensus statementCharacterization of Cre recombinase models for the study of adipose tissuePPAR gamma and human metabolic diseaseAcquired generalized lipodystrophy associated with autoimmune hepatitis and low serum C4 level.Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.Lipodystrophy syndromesThematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism.Dense deposit disease.Lipodystrophy: pathophysiology and advances in treatmentGenetics in endocrinology: genetic forms of severe insulin resistance: what endocrinologists should know.Clinical features and outcomes of 98 children and adults with dense deposit disease.Barraquer-Simons syndrome: a rare form of acquired lipodystrophy.Recurrent stroke as a presenting feature of acquired partial lipodystrophy.Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulationImpaired expression of mitochondrial and adipogenic genes in adipose tissue from a patient with acquired partial lipodystrophy (Barraquer-Simons syndrome): a case report.Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity.Lipodystrophies: disorders of adipose tissue biology.Adipocyte lineages: tracing back the origins of fat.Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy.Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access Program.Dense deposit disease and C3 glomerulopathyType 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapyThe Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.Dermatomyositis Leading to Necrotizing Vasculitis: A Perfect Response to Applied Therapy.American Society of Nephrology clinical pathological conference.Mechanistic insights into insulin resistance in the genetic era.Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies.Lipodystrophies: adipose tissue disorders with severe metabolic implications.Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies.Genetics of Lipodystrophy.Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges.Long-term fundus changes in acquired partial lipodystrophy.Barraquer-Simons syndrome: a unique patient's perspective on diagnosis, disease progression and recontouring treatment.Pediatric Hematuria Remains a Clinical Dilemma.Effects of Metreleptin in Pediatric Patients With Lipodystrophy.
P2860
Q24678764-DC88E1D8-0341-44FA-81A7-2EDF258F0129Q28972389-C92D478C-DC74-450F-B60E-26139C55BD3BQ33277954-A8FE94B4-BBE2-45A4-8B4B-0F901F0C9437Q33594434-2C55C718-3F6C-49DE-A0F6-1E01BF7B2953Q33787727-FE7B30AE-75DB-420E-9B32-9C5320BDABDEQ33939518-256489DA-064B-47B6-A7B4-578348F6A7E6Q33946398-2C092DB2-0C1D-4189-A0DD-7DAF185C1AA5Q34416432-31E3DFEB-5DDF-4980-8094-9FBF800FF4EEQ34423154-4582010D-645E-4FB9-A838-46D5C45CC97FQ34427591-1866A719-8E74-4336-B5B0-F7CF62B3D8D7Q34597209-F06DD9BB-863D-42AF-A2F2-34D1773E7AB0Q34610713-916C18FB-4343-4C4B-B136-DB99341D49A4Q35124165-68249DFA-2DD8-48B9-931F-4B99003E8DBEQ35148915-DA3CCF96-9939-4448-9BDF-3AAD8B87BF43Q35178218-D8C70371-5D42-48F2-B37D-39584DAE3E43Q35580577-2DDE7960-1BDA-41B9-8F79-78466DB704A8Q35961396-95883E12-EF14-41B5-B60C-B476D073B15FQ36701330-28559F79-FC5C-498C-837D-B7DCF6D1CFB6Q36718519-8EABA289-FAD2-42FA-805F-D24B6C40F9EFQ36870336-30F0C529-A867-4B96-BBE3-627D5806153DQ37172923-0A5CDF78-8CE5-4213-88F1-DBABDD76E1C2Q37219869-D3150B11-03A0-4D06-BA33-DBD2FC28D650Q37248700-FBF46D55-87CD-492A-B474-38F51148B06CQ37259059-29337A37-23F4-4206-8268-681FB88D1AE4Q37261712-9B0D199A-6411-4B35-AB8A-A28A93164A22Q37286653-6E448E08-A631-45B9-A270-9FDD8C4251ABQ37311122-775940CA-55EB-45DA-B600-50AC83D52A3FQ37502548-F57384FF-440E-4AE3-9ECE-4D3DF3B5851CQ37608074-A74B4716-A645-4870-9034-8D3C9D1E4252Q37682273-F5988EFA-C265-41D0-9C32-2C58D9589D7EQ37944891-7D311B6B-E05B-4030-A2BC-3B1C2E1B8DD6Q38155007-9D4E6D26-A16E-4B9E-B500-D6D2EB8DCC36Q38400624-C9DBB4A5-E858-4FF0-9CCF-B2F143D62E02Q38880897-98536371-BD5A-4747-A6A4-E9957BC86A47Q39286374-99B9179A-E4B8-4AD2-AB70-9D2B2491B6DCQ42736020-B53A998E-F4A2-4EE0-A97F-9365B66B9EFAQ42866799-20CC13D2-9C08-4024-98D1-647B08477C62Q47700392-B6B8F752-CAC8-4C83-980E-374D0D6179B4Q47809622-64277F02-63F8-44A7-B515-B48480930E65Q47821479-D9E5C5E0-440B-4DF1-92EA-E5C0B3E2C822
P2860
Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Clinical features and metaboli ...... and review of the literature.
@ast
Clinical features and metaboli ...... and review of the literature.
@en
Clinical features and metaboli ...... and review of the literature.
@nl
type
label
Clinical features and metaboli ...... and review of the literature.
@ast
Clinical features and metaboli ...... and review of the literature.
@en
Clinical features and metaboli ...... and review of the literature.
@nl
prefLabel
Clinical features and metaboli ...... and review of the literature.
@ast
Clinical features and metaboli ...... and review of the literature.
@en
Clinical features and metaboli ...... and review of the literature.
@nl
P2093
P1433
P1476
Clinical features and metaboli ...... and review of the literature.
@en
P2093
Abhimanyu Garg
Anoop Misra
Aparna Peethambaram
P356
10.1097/01.MD.0000111061.69212.59
P407
P577
2004-01-01T00:00:00Z